Short-term efficacy of dapagliflozin in children with hereditary proteinuric kidney disease

Objective: To explore the short-term efficacy and safety of dapagliflozin in children with hereditary proteinuric kidney disease. Methods: This was a prospective cohort study. From August 2020 to December 2021, 23 children with hereditary kidney disease from Children's Hospital of Fudan Univers...

Description complète

Détails bibliographiques
Publié dans:Zhonghua er ke za zhi = Chinese journal of pediatrics. - 1960. - 61(2023), 2 vom: 02. Feb., Seite 164-168
Auteur principal: Cui, J Y (Auteur)
Autres auteurs: Liu, J J, Fang, X Y, Chen, J, Zhai, Y H, Xu, H, Shen, Q
Format: Article en ligne
Langue:Chinese
Publié: 2023
Accès à la collection:Zhonghua er ke za zhi = Chinese journal of pediatrics
Sujets:English Abstract Journal Article dapagliflozin 1ULL0QJ8UC Serum Albumin